Patient-derived organoid models of metastatic colorectal cancer to study response to PIK3CA inhibitors

被引：0
|
作者：
Barros Silva, J. D. [1 ]
Wanigasooriya, K. [1 ]
Bermingham, H. [1 ]
Patel, S. [1 ]
Hoare, R. [1 ]
Stodolna, A. [1 ]
Pickles, O. [1 ]
Bryer, C. [1 ]
Whalley, C. [1 ]
Beggs, A. [1 ]
机构：
[1] Univ Birmingham, Inst Canc & Genom Sci, Canc Genom, Birmingham, W Midlands, England
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz413.094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
90P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Development of Patient-Derived Colorectal Cancer Xenograft and Organoid Models with Acquired Resistance to KRAS G12C Inhibitors
    Hua, L.
    Zheng, J.
    Wang, J.
    Shang, L.
    Qian, W.
    Sun, Y.
    Bourre, L.
    Wang, J.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S104 - S105
  • [32] Patient-derived Organoid Model for Predicting the Chemoresponse in Patients With Colorectal Cancer
    Yi, Kiyoun
    Park, Sung Hee
    Kim, Dong Uk
    Jeon, Da Ye
    Lee, Hye Ji
    Song, Geun Am
    Jo, Hong Jae
    Baek, Dong Hoon
    Han, Jeong Hee
    Lee, Byoung Chul
    IN VIVO, 2023, 37 (04): : 1751 - 1759
  • [33] Prognostic value of PIK3CA gene assessment in tissue & plasma in metastatic colorectal cancer (mCRC)
    Brage, E. Teran
    Tocino, R. Vidal
    Puertas, P. Reguera
    Mateos, Y. Lopez
    Gutierrez, A. Lopez
    Hernandez, M. M. Abad
    Manzano, J. Sayagues
    Rodrigues, A.
    Montero-Gonzalez, J.
    Araujo, D. Morchon
    Gonzalez, J. C. Redondo
    Mejorada, R. Lozano
    Sanchez, E. Fonseca
    ANNALS OF ONCOLOGY, 2024, 35 : S49 - S49
  • [34] PIK3CA mutation and methylation influences the outcome of colorectal cancer
    Iida, Satoru
    Kato, Shunsuke
    Ishiguro, Megumi
    Matsuyama, Takatoshi
    Ishikawa, Toshiaki
    Kobayashi, Hirotoshi
    Higuchi, Tetsuro
    Uetake, Hiroyuki
    Enomoto, Masayuki
    Sugihara, Kenichi
    ONCOLOGY LETTERS, 2012, 3 (03) : 565 - 570
  • [35] KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
    De Roock, Wendy
    De Vriendt, Veerle
    Normanno, Nicola
    Ciardiello, Fortunato
    Tejpar, Sabine
    LANCET ONCOLOGY, 2011, 12 (06): : 594 - 603
  • [36] Aspirin, PIK3CA Mutation, and Colorectal-Cancer Survival
    Sahin, Ibrahim H.
    Garrett, Christopher
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03): : 289 - 289
  • [37] Treatment of a Patient with PIK3CA mutant metastatic Porocarcinoma with Alpelisib and Radiotherapy
    Horbruegger, M.
    Lenz, F. S.
    Franke, I.
    Tueting, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 6 - 6
  • [38] Patient-derived organoid-based models for endometrial cancer.
    Berg, Hege F.
    Fonnes, Tina
    Strand, Elin
    Espedal, Heidi
    Stefansson, Ingunn M.
    McCormack, Emmet
    Bjorge, Line
    Trovik, Jone
    Haldorsen, Ingfrid S.
    Hoyvik, Erling A.
    Krakstad, Camilla
    CANCER RESEARCH, 2020, 80 (11) : 41 - 41
  • [39] Modeling radiation sensitivity in patient-derived organoid models of endometrial cancer
    Gabrilovich, Sofia
    Powell-Smith, Kaitriana
    Sumanasiri, Hiruni
    Symons, Emily
    Hill, Emily
    Pufall, Miles
    Santillan, Donna
    Thiel, Kristina W.
    CLINICAL CANCER RESEARCH, 2024, 30 (05)
  • [40] MANAGEMENT OF HYPERGLYCEMIA IN PATIENT S RECEIVING PIK3CA INHIBITORS.
    Colella, Sarah
    Worth, Clare
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
12345